Annual Cost Of Goods Sold
$12.83 B
+$355.00 M+2.85%
December 31, 2024
Summary
- As of February 7, 2025, NVS annual cost of goods sold is $12.83 billion, with the most recent change of +$355.00 million (+2.85%) on December 31, 2024.
- During the last 3 years, NVS annual cost of goods sold has risen by +$1.09 billion (+9.31%).
- NVS annual cost of goods sold is now -32.43% below its all-time high of $18.98 billion, reached on December 31, 2011.
Performance
NVS Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cost Of Goods Sold
$3.32 B
+$90.00 M+2.78%
December 31, 2024
Summary
- As of February 7, 2025, NVS quarterly cost of goods sold is $3.32 billion, with the most recent change of +$90.00 million (+2.78%) on December 31, 2024.
- Over the past year, NVS quarterly cost of goods sold has increased by +$302.00 million (+9.99%).
- NVS quarterly cost of goods sold is now -35.05% below its all-time high of $5.12 billion, reached on December 31, 2011.
Performance
NVS Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Cost Of Goods Sold
$12.83 B
+$302.00 M+2.41%
December 31, 2024
Summary
- As of February 7, 2025, NVS TTM cost of goods sold is $12.83 billion, with the most recent change of +$302.00 million (+2.41%) on December 31, 2024.
- Over the past year, NVS TTM cost of goods sold has increased by +$355.00 million (+2.85%).
- NVS TTM cost of goods sold is now -32.52% below its all-time high of $19.01 billion, reached on March 31, 2012.
Performance
NVS TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cost Of Goods Sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
NVS Cost Of Goods Sold Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.9% | +10.0% | +2.9% |
| 3 y3 years | +9.3% | +6.6% | +2.7% |
| 5 y5 years | -11.1% | +6.6% | +2.7% |
NVS Cost Of Goods Sold Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.8% | -13.8% | +2230.8% | -5.1% | +24.2% |
| 5 y | 5-year | -15.2% | +10.8% | -21.2% | +2230.8% | -20.4% | +24.2% |
| alltime | all time | -32.4% | +170.4% | -35.0% | +2230.8% | -32.5% | +1112.4% |
Novartis AG Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $12.83 B(+2.8%) | $3.32 B(+2.8%) | $12.83 B(+2.4%) |
| Sep 2024 | - | $3.23 B(+1.9%) | $12.53 B(+0.9%) |
| Jun 2024 | - | $3.17 B(+2.5%) | $12.41 B(-1.3%) |
| Mar 2024 | - | $3.10 B(+2.4%) | $12.58 B(+0.8%) |
| Dec 2023 | $12.47 B(+7.7%) | $3.02 B(-3.0%) | $12.47 B(-0.2%) |
| Sep 2023 | - | $3.12 B(-6.7%) | $12.49 B(+2.0%) |
| Jun 2023 | - | $3.34 B(+11.7%) | $12.25 B(-3.2%) |
| Mar 2023 | - | $2.99 B(-1.6%) | $12.66 B(-6.4%) |
| Dec 2022 | $11.58 B(-1.3%) | $3.04 B(+5.8%) | $13.52 B(+31.0%) |
| Sep 2022 | - | $2.87 B(-23.4%) | $10.32 B(-9.3%) |
| Jun 2022 | - | $3.75 B(-2.7%) | $11.39 B(-1.4%) |
| Mar 2022 | - | $3.86 B(-2571.8%) | $11.55 B(-1.6%) |
| Dec 2021 | $11.73 B(-22.4%) | -$156.00 M(-104.0%) | $11.73 B(-27.1%) |
| Sep 2021 | - | $3.94 B(+0.6%) | $16.11 B(+1.2%) |
| Jun 2021 | - | $3.91 B(-3.1%) | $15.92 B(+3.1%) |
| Mar 2021 | - | $4.04 B(-4.2%) | $15.44 B(+2.1%) |
| Dec 2020 | $15.12 B(+4.8%) | $4.22 B(+12.4%) | $15.12 B(+1.5%) |
| Sep 2020 | - | $3.75 B(+9.4%) | $14.90 B(-0.2%) |
| Jun 2020 | - | $3.43 B(-7.9%) | $14.92 B(+0.2%) |
| Mar 2020 | - | $3.72 B(-6.8%) | $14.90 B(+3.3%) |
| Dec 2019 | $14.43 B(-0.6%) | $3.99 B(+5.7%) | $14.43 B(-0.3%) |
| Sep 2019 | - | $3.78 B(+10.9%) | $14.47 B(+2.2%) |
| Jun 2019 | - | $3.41 B(+4.8%) | $14.16 B(-1.1%) |
| Mar 2019 | - | $3.25 B(-19.5%) | $14.31 B(-1.4%) |
| Dec 2018 | $14.51 B(+6.4%) | $4.04 B(+16.6%) | $14.51 B(+27.1%) |
| Sep 2018 | - | $3.46 B(-2.7%) | $11.42 B(-7.0%) |
| Jun 2018 | - | $3.56 B(+3.1%) | $12.28 B(-5.4%) |
| Mar 2018 | - | $3.45 B(+264.4%) | $12.98 B(-4.8%) |
| Dec 2017 | $13.63 B(-22.2%) | $947.00 M(-78.1%) | $13.63 B(-20.6%) |
| Sep 2017 | - | $4.32 B(+1.5%) | $17.18 B(-0.3%) |
| Jun 2017 | - | $4.26 B(+3.7%) | $17.22 B(-1.1%) |
| Mar 2017 | - | $4.11 B(-8.6%) | $17.41 B(-0.6%) |
| Dec 2016 | $17.52 B(+0.7%) | $4.49 B(+2.8%) | $17.52 B(-0.3%) |
| Sep 2016 | - | $4.37 B(-1.9%) | $17.58 B(-0.1%) |
| Jun 2016 | - | $4.45 B(+5.7%) | $17.60 B(-0.2%) |
| Mar 2016 | - | $4.21 B(-7.4%) | $17.64 B(+1.3%) |
| Dec 2015 | $17.40 B(+0.3%) | $4.55 B(+3.7%) | $17.40 B(+0.8%) |
| Sep 2015 | - | $4.39 B(-2.2%) | $17.27 B(-0.2%) |
| Jun 2015 | - | $4.49 B(+12.7%) | $17.30 B(+0.6%) |
| Mar 2015 | - | $3.98 B(-9.9%) | $17.20 B(-0.9%) |
| Dec 2014 | $17.34 B(+4.6%) | $4.42 B(-0.1%) | $17.34 B(-0.1%) |
| Sep 2014 | - | $4.42 B(+1.0%) | $17.36 B(+1.7%) |
| Jun 2014 | - | $4.38 B(+6.0%) | $17.06 B(+1.7%) |
| Mar 2014 | - | $4.13 B(-6.7%) | $16.77 B(-2.8%) |
| Dec 2013 | $16.58 B(+4.5%) | $4.43 B(+7.3%) | $17.25 B(+14.9%) |
| Sep 2013 | - | $4.13 B(+1.0%) | $15.02 B(-2.9%) |
| Jun 2013 | - | $4.09 B(-11.3%) | $15.46 B(-3.3%) |
| Mar 2013 | - | $4.61 B(+109.6%) | $15.99 B(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $15.87 B(-16.4%) | $2.20 B(-52.0%) | $15.87 B(-15.5%) |
| Sep 2012 | - | $4.58 B(-0.8%) | $18.79 B(-1.1%) |
| Jun 2012 | - | $4.61 B(+2.8%) | $19.00 B(-0.0%) |
| Mar 2012 | - | $4.48 B(-12.4%) | $19.01 B(+0.1%) |
| Dec 2011 | $18.98 B(+31.0%) | $5.12 B(+6.9%) | $18.98 B(+3.2%) |
| Sep 2011 | - | $4.79 B(+3.7%) | $18.39 B(+6.5%) |
| Jun 2011 | - | $4.62 B(+3.6%) | $17.26 B(+8.9%) |
| Mar 2011 | - | $4.46 B(-1.5%) | $15.85 B(+9.4%) |
| Dec 2010 | $14.49 B(+19.0%) | $4.52 B(+23.5%) | $14.49 B(+6.3%) |
| Sep 2010 | - | $3.66 B(+14.2%) | $13.63 B(+4.3%) |
| Jun 2010 | - | $3.21 B(+3.6%) | $13.07 B(+3.0%) |
| Mar 2010 | - | $3.10 B(-15.6%) | $12.69 B(+2.3%) |
| Dec 2009 | $12.18 B(+6.5%) | $3.67 B(+18.2%) | $12.40 B(+7.2%) |
| Sep 2009 | - | $3.10 B(+9.9%) | $11.57 B(+0.7%) |
| Jun 2009 | - | $2.82 B(+0.6%) | $11.49 B(-1.0%) |
| Mar 2009 | - | $2.81 B(-0.9%) | $11.60 B(+1.4%) |
| Dec 2008 | $11.44 B(+3.7%) | $2.83 B(-6.2%) | $11.44 B(-1.5%) |
| Sep 2008 | - | $3.02 B(+2.9%) | $11.62 B(-0.1%) |
| Jun 2008 | - | $2.94 B(+10.9%) | $11.63 B(+3.9%) |
| Mar 2008 | - | $2.65 B(-12.1%) | $11.19 B(+1.5%) |
| Dec 2007 | $11.03 B(+17.2%) | $3.01 B(-0.7%) | $11.03 B(+3.1%) |
| Sep 2007 | - | $3.03 B(+21.5%) | $10.70 B(+5.0%) |
| Jun 2007 | - | $2.50 B(+0.4%) | $10.19 B(+2.7%) |
| Mar 2007 | - | $2.49 B(-7.1%) | $9.92 B(+3.2%) |
| Dec 2006 | $9.41 B(+26.5%) | $2.68 B(+5.9%) | $9.61 B(+19.8%) |
| Sep 2006 | - | $2.53 B(+13.7%) | $8.02 B(+1.0%) |
| Jun 2006 | - | $2.23 B(+2.0%) | $7.95 B(+3.2%) |
| Mar 2006 | - | $2.18 B(+100.6%) | $7.70 B(+4.5%) |
| Dec 2005 | $7.44 B(+11.0%) | $1.09 B(-55.6%) | $7.37 B(-10.6%) |
| Sep 2005 | - | $2.45 B(+24.1%) | $8.23 B(+11.3%) |
| Jun 2005 | - | $1.98 B(+6.6%) | $7.40 B(+5.4%) |
| Mar 2005 | - | $1.85 B(-5.3%) | $7.02 B(+4.7%) |
| Dec 2004 | $6.70 B(+3.8%) | $1.96 B(+21.3%) | $6.70 B(-3.1%) |
| Sep 2004 | - | $1.61 B(+1.2%) | $6.91 B(+1.7%) |
| Jun 2004 | - | $1.59 B(+3.8%) | $6.80 B(+2.6%) |
| Mar 2004 | - | $1.54 B(-29.2%) | $6.63 B(+2.7%) |
| Dec 2003 | $6.46 B(+29.3%) | $2.17 B(+44.7%) | $6.46 B(+15.3%) |
| Sep 2003 | - | $1.50 B(+5.4%) | $5.60 B(+5.4%) |
| Jun 2003 | - | $1.42 B(+4.4%) | $5.31 B(+2.4%) |
| Mar 2003 | - | $1.36 B(+3.8%) | $5.18 B(+35.7%) |
| Dec 2002 | $4.99 B(+5.3%) | $1.31 B(+8.4%) | $3.82 B(+52.4%) |
| Sep 2002 | - | $1.21 B(-6.6%) | $2.51 B(+93.4%) |
| Jun 2002 | - | $1.30 B(+22.4%) | $1.30 B(+22.4%) |
| Dec 2001 | $4.74 B(-25.2%) | - | - |
| Jun 2001 | - | $1.06 B(+0.2%) | $1.06 B(+0.2%) |
| Dec 2000 | $6.35 B(+21.6%) | - | - |
| Jun 2000 | - | $1.06 B | $1.06 B |
| Dec 1999 | $5.22 B(-28.5%) | - | - |
| Dec 1998 | $7.31 B | - | - |
FAQ
- What is Novartis AG annual cost of goods sold?
- What is the all time high annual cost of goods sold for Novartis AG?
- What is Novartis AG annual cost of goods sold year-on-year change?
- What is Novartis AG quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Novartis AG?
- What is Novartis AG quarterly cost of goods sold year-on-year change?
- What is Novartis AG TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Novartis AG?
- What is Novartis AG TTM cost of goods sold year-on-year change?
What is Novartis AG annual cost of goods sold?
The current annual cost of goods sold of NVS is $12.83 B
What is the all time high annual cost of goods sold for Novartis AG?
Novartis AG all-time high annual cost of goods sold is $18.98 B
What is Novartis AG annual cost of goods sold year-on-year change?
Over the past year, NVS annual cost of goods sold has changed by +$355.00 M (+2.85%)
What is Novartis AG quarterly cost of goods sold?
The current quarterly cost of goods sold of NVS is $3.32 B
What is the all time high quarterly cost of goods sold for Novartis AG?
Novartis AG all-time high quarterly cost of goods sold is $5.12 B
What is Novartis AG quarterly cost of goods sold year-on-year change?
Over the past year, NVS quarterly cost of goods sold has changed by +$302.00 M (+9.99%)
What is Novartis AG TTM cost of goods sold?
The current TTM cost of goods sold of NVS is $12.83 B
What is the all time high TTM cost of goods sold for Novartis AG?
Novartis AG all-time high TTM cost of goods sold is $19.01 B
What is Novartis AG TTM cost of goods sold year-on-year change?
Over the past year, NVS TTM cost of goods sold has changed by +$355.00 M (+2.85%)